Arkin Holdings

Arkin Holdings is a prominent Israeli private investment firm specializing in healthcare and real estate sectors. The firm focuses on empowering companies that develop breakthrough technologies in pharmaceuticals, biotechnology, medical devices, and digital health, aiming to enhance medical care and benefit humanity. Additionally, Arkin Holdings invests in real estate projects, leveraging its expertise to identify and develop high-potential properties.

The firm's investment strategy encompasses various stages, including early-stage, growth, late-stage, pre-IPO, and buyout opportunities. Arkin Holdings has a diverse geographical focus, with investments in Israel, the United States, and Europe. Its portfolio spans multiple industries, such as pharmaceuticals, biotechnology, medical devices, digital health, healthcare, technology, and real estate.

Arkin Holdings has a proven track record of successful investments, including notable exits in companies like HI-Bio, BioSight, and cCAM Biotherapeutics. The firm's founder and chairman, Mori Arkin, is a seasoned entrepreneur with extensive experience in the pharmaceutical industry, having previously sold Agis Industries to Perrigo for $390 million. Under his leadership, Arkin Holdings continues to make significant contributions to the healthcare and real estate sectors, supporting innovative companies and projects that align with its strategic vision.